May 26, 2026

Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This Medical News article discusses findings that genetic variants may affect patients’ responses to glucagon-like peptide-1 receptor agonists such as semaglutide and tirzepatide.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Samantha Anderer (Fri,) studied this question.

synapsesocial.com/papers/6a160e5155486f20af85f736 — DOI: https://doi.org/10.1001/jama.2026.6177

Authors

Samantha Anderer

Journals

JAMA

Actions

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics

Puntos clave

Resumen

Citation Network

Connected Papers

Discussion

Cite this study

Authors

Journals

Actions

References and Citations

Citation Network

Connected Papers

Discussion